Table 21.
Cumulative survival rates for hepatocellular carcinoma treated with transcatheter arterial chemoembolization (in patients registered between 1998 and 2009)
| Fig. No. | Title | Category name | n | Survival rate (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median OS (months) | 1 year | 2 years | 3 years | 4 years | 5 years | 6 years | 7 years | 8 years | 9 years | 10 years | ||||
| All patients | 22 695 | 37.62 | 82.3 | 65.2 | 51.7 | 40.1 | 32.0 | 25.3 | 20.5 | 16.9 | 15.1 | 11.8 | ||
| Fig. 7 | Child–Pugh grade | Child–Pugh A | 12 134 | 46.06 | 87.2 | 72.6 | 59.9 | 48.5 | 40.0 | 32.2 | 26.0 | 21.3 | 19.0 | 11.3 |
| Child–Pugh B | 4803 | 27.83 | 77.0 | 55.8 | 39.2 | 26.2 | 19.2 | 14.5 | 10.4 | 8.9 | 7.5 | – | ||
| Child–Pugh C | 686 | 16.16 | 59.6 | 35.5 | 23.8 | 16.6 | 12.2 | 9.2 | 7.0 | 7.0 | 7.0 | – | ||
| Fig. 8 | No. tumors | 1 | 9406 | 47.34 | 87.1 | 73.6 | 61.4 | 49.4 | 41.1 | 33.4 | 27.6 | 23.5 | 20.6 | 15.3 |
| 2 | 4347 | 41.07 | 86.3 | 69.5 | 55.5 | 41.7 | 31.3 | 24.0 | 18.6 | 13.5 | 12.4 | 10.4 | ||
| 3 | 2541 | 33.48 | 84.6 | 64.5 | 47.4 | 34.4 | 26.1 | 20.3 | 14.9 | 13.4 | 12.4 | 11.0 | ||
| 4 | 1232 | 31.47 | 84.5 | 61.5 | 42.9 | 32.3 | 24.2 | 17.6 | 14.0 | 9.3 | 9.3 | 8.0 | ||
| ≥5 | 4565 | 21.19 | 68.1 | 46.1 | 32.8 | 23.8 | 18.2 | 14.7 | 12.6 | 10.3 | 8.6 | 6.6 | ||
OS, overall survival.